Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-52,500
Closed -$289K 561
2025
Q3
$289K Buy
+52,500
New +$285K 0.01% 405
2025
Q1
Sell
-580,700
Closed -$2.94M 473
2024
Q4
$2.94M Buy
580,700
+310,700
+115% +$1.72M 0.08% 243
2024
Q3
$1.86M Buy
+270,000
New +$1.59M 0.05% 234
2023
Q1
Sell
-105,000
Closed -$299K 357
2022
Q4
$299K Buy
+105,000
New +$178K 0.01% 291
2020
Q3
Sell
-30,000
Closed -$208K 304
2020
Q2
$208K Buy
+30,000
New +$209K 0.01% 250

Other funds holding ARDX

J. Goldman & Co's ARDX Position: Q1 2026 in Review

J. Goldman & Co increased its Ardelyx (ARDX) stake by 85% in Q1 2026, buying an estimated $9.11M and bringing the position to 3,000,513 shares worth $18M. The position accounts for 0.52% of the portfolio, ranked #43.

J. Goldman & Co first reported a position in ARDX in Q4 2019 and has held it in 13 quarters since. 239 funds tracked by Wall St. Rank hold ARDX as of Q1 2026.

  • J. Goldman & Co held 3,000,513 shares of Ardelyx worth $18M as of Q1 2026.
  • J. Goldman & Co bought 1,377,777 Ardelyx shares in Q1 2026, an estimated $9.11M.
  • Ardelyx made up 0.52% of J. Goldman & Co's portfolio in Q1 2026, its #43 holding.
  • J. Goldman & Co first reported a position in Ardelyx in Q4 2019 and has held it in 13 quarters since.
  • 239 funds tracked by Wall St. Rank held Ardelyx as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.